Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000899243-21-026781

Chief Executive Officer acquired 32 shares (other)

  • Chief Executive Officer acquired 64 shares (code L)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Evans John M. Chief Executive Officer 2021-06-25 Other acquisition +32 1,021,461 D
Evans John M. Chief Executive Officer 2021-06-28 Other acquisition +32 1,021,493 D
Evans John M. Chief Executive Officer 2021-06-29 Other acquisition +32 1,021,525 D
Loading xslF345X03/doc4.xml…